Loading...
XNAS:STTK
SHATTUCK LABS, INC. shares are trading lower as the market reacts to uncertainty around the newly announced $103 million private placement and significant changes to the Board of Directors.
Shattuck Labs shares are trading higher after the company announced an oversubscribed private placement raising up to $103 million to fund clinical trials for its drug SL-325.